JP2005506294A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005506294A5 JP2005506294A5 JP2002574974A JP2002574974A JP2005506294A5 JP 2005506294 A5 JP2005506294 A5 JP 2005506294A5 JP 2002574974 A JP2002574974 A JP 2002574974A JP 2002574974 A JP2002574974 A JP 2002574974A JP 2005506294 A5 JP2005506294 A5 JP 2005506294A5
- Authority
- JP
- Japan
- Prior art keywords
- tegafur
- use according
- uracil
- administered
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims 8
- DHMYGZIEILLVNR-UHFFFAOYSA-N 5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione;1h-pyrimidine-2,4-dione Chemical compound O=C1C=CNC(=O)N1.O=C1NC(=O)C(F)=CN1C1OCCC1 DHMYGZIEILLVNR-UHFFFAOYSA-N 0.000 claims 6
- KVUAALJSMIVURS-ZEDZUCNESA-L calcium folinate Chemical compound [Ca+2].C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)C=C1 KVUAALJSMIVURS-ZEDZUCNESA-L 0.000 claims 6
- WFWLQNSHRPWKFK-ZCFIWIBFSA-N tegafur Chemical compound O=C1NC(=O)C(F)=CN1[C@@H]1OCCC1 WFWLQNSHRPWKFK-ZCFIWIBFSA-N 0.000 claims 6
- 229960001674 tegafur Drugs 0.000 claims 6
- 229930012538 Paclitaxel Natural products 0.000 claims 5
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 claims 5
- 229960004562 carboplatin Drugs 0.000 claims 5
- 229960001592 paclitaxel Drugs 0.000 claims 5
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 5
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 claims 4
- MPJKWIXIYCLVCU-UHFFFAOYSA-N Folinic acid Natural products NC1=NC2=C(N(C=O)C(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)CC(=O)O)CN2)C(=O)N1 MPJKWIXIYCLVCU-UHFFFAOYSA-N 0.000 claims 4
- 235000008191 folinic acid Nutrition 0.000 claims 4
- 239000011672 folinic acid Substances 0.000 claims 4
- 229960001691 leucovorin Drugs 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 229940035893 uracil Drugs 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 235000008207 calcium folinate Nutrition 0.000 claims 2
- 239000011687 calcium folinate Substances 0.000 claims 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 1
- 206010061968 Gastric neoplasm Diseases 0.000 claims 1
- 210000003236 esophagogastric junction Anatomy 0.000 claims 1
- 210000003238 esophagus Anatomy 0.000 claims 1
- 229960002949 fluorouracil Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27357701P | 2001-03-06 | 2001-03-06 | |
| PCT/US2002/006262 WO2002076459A1 (en) | 2001-03-06 | 2002-03-04 | Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005506294A JP2005506294A (ja) | 2005-03-03 |
| JP2005506294A5 true JP2005506294A5 (cg-RX-API-DMAC7.html) | 2005-12-22 |
Family
ID=23044526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002574974A Pending JP2005506294A (ja) | 2001-03-06 | 2002-03-04 | テガフル、ウラシル、フォリン酸、パクリタキセルおよびカルボプラチンの投与による腫瘍の治療方法および剤形 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6770653B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1368034A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005506294A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20030081496A (cg-RX-API-DMAC7.html) |
| BR (1) | BR0207443A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2439676A1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ20032266A3 (cg-RX-API-DMAC7.html) |
| EE (1) | EE200300429A (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20030801A2 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0303466A3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL157357A0 (cg-RX-API-DMAC7.html) |
| IS (1) | IS6925A (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03007989A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20033910L (cg-RX-API-DMAC7.html) |
| PL (1) | PL363967A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2284184C2 (cg-RX-API-DMAC7.html) |
| SK (1) | SK10602003A3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002076459A1 (cg-RX-API-DMAC7.html) |
| YU (1) | YU69903A (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200306541B (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100374162C (zh) * | 2000-11-06 | 2008-03-12 | 法马马有限公司 | 海鞘素－743在制备用于治疗肿瘤的药剂中的应用 |
| JP4610481B2 (ja) | 2003-03-14 | 2011-01-12 | 大鵬薬品工業株式会社 | 抗腫瘍効果増強剤及び抗腫瘍剤 |
| WO2004087105A1 (en) * | 2003-04-02 | 2004-10-14 | Celator Pharmaceuticals, Inc. | Combination formulations of platinum agents and fluoropyrimidines |
| GB0312407D0 (en) * | 2003-05-29 | 2003-07-02 | Pharma Mar Sau | Treatment |
| GB0326486D0 (en) * | 2003-11-14 | 2003-12-17 | Pharma Mar Sau | Combination treatment |
| US20080255132A1 (en) * | 2003-11-14 | 2008-10-16 | Eric Rowinsky | Combination Therapy Comprising the Use of Et-743 and Paclitaxel for Treating Cancer |
| KR20050099311A (ko) * | 2004-04-09 | 2005-10-13 | 에이엔에이치 케어연구소(주) | 주사제용 항암제 조성물 |
| JP4554684B2 (ja) * | 2004-10-26 | 2010-09-29 | ファルマ・マル・エス・アー， ソシエダッド・ユニペルソナル | 抗癌治療 |
| KR101188691B1 (ko) | 2004-10-29 | 2012-10-09 | 파르마 마르 에스.에이. | 엑티나시딘 및 디사카라이드를 포함하는 제제 |
| US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| SI2301531T1 (sl) | 2005-02-18 | 2018-11-30 | Abraxis Bioscience, Llc | Kombinacije in načini dajanja terapevtskih sredstev in kombinacijska terapija |
| GB0522082D0 (en) * | 2005-10-31 | 2005-12-07 | Pharma Mar Sa | Formulations |
| AU2008202078B2 (en) * | 2007-10-10 | 2012-05-31 | Wellkey Holdings Limited | Stability of secondary metabolite mass production through synchronized plant cell cultures |
| JP2011500046A (ja) * | 2007-10-19 | 2011-01-06 | ファルマ・マール・ソシエダード・アノニマ | Ｅｔ−７４３治療のための予後分子マーカー |
| RU2016119999A (ru) | 2010-03-29 | 2018-11-08 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Способы лечения онкологических заболеваний |
| CN105147613A (zh) | 2010-03-29 | 2015-12-16 | 阿布拉科斯生物科学有限公司 | 增强药物递送和治疗剂有效性的方法 |
| EP2575804A4 (en) | 2010-06-04 | 2013-10-23 | Abraxis Bioscience Llc | METHOD FOR THE TREATMENT OF PANCREASCRE |
| CA2983411C (en) * | 2015-04-22 | 2023-02-21 | Syn-Nat Products Enterprise LLC | Co-crystal composition and its pharmaceutical use |
| JP7008025B2 (ja) | 2016-08-31 | 2022-01-25 | 富士フイルム株式会社 | 抗腫瘍剤、抗腫瘍効果増強剤及び抗腫瘍用キット |
| RU2646450C1 (ru) * | 2017-05-11 | 2018-03-05 | Владимир Михайлович Курусин | Способ лечения предраковых и ранних стадий раковых заболеваний желудка |
| AU2018404329B2 (en) | 2018-01-29 | 2021-09-09 | Fujifilm Corporation | Antitumor agent for biliary tract cancer and method for treating biliary tract cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5A (en) * | 1836-08-10 | Thomas Blanchard | Machine for mortising solid wooden shells of ships' tackle-blocks | |
| US4328229A (en) | 1978-03-29 | 1982-05-04 | Taiho Pharmaceutical Company Limited | Anti-cancer composition for delivering 5-fluorouracil to cancer tissues |
| US5534513A (en) | 1991-09-05 | 1996-07-09 | Taiho Pharmaceutical Company, Ltd. | Antitumor potentiator and antitumor composition |
| FR2697752B1 (fr) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
| US5919816A (en) * | 1994-11-14 | 1999-07-06 | Bionumerik Pharmaceuticals, Inc. | Formulations and methods of reducing toxicity of antineoplastic agents |
| RU2194541C1 (ru) * | 2001-07-13 | 2002-12-20 | Научно-исследовательский институт онкологии Томского научного центра СО РАН | Способ комбинированного лечения больных местнораспространенным раком желудка |
-
2002
- 2002-03-04 IL IL15735702A patent/IL157357A0/xx unknown
- 2002-03-04 HR HR20030801A patent/HRP20030801A2/hr not_active Application Discontinuation
- 2002-03-04 RU RU2003129527/14A patent/RU2284184C2/ru not_active IP Right Cessation
- 2002-03-04 KR KR10-2003-7011636A patent/KR20030081496A/ko not_active Withdrawn
- 2002-03-04 SK SK10602003A patent/SK10602003A3/sk not_active Application Discontinuation
- 2002-03-04 CA CA002439676A patent/CA2439676A1/en not_active Abandoned
- 2002-03-04 MX MXPA03007989A patent/MXPA03007989A/es unknown
- 2002-03-04 WO PCT/US2002/006262 patent/WO2002076459A1/en not_active Ceased
- 2002-03-04 US US10/090,354 patent/US6770653B2/en not_active Expired - Fee Related
- 2002-03-04 HU HU0303466A patent/HUP0303466A3/hu unknown
- 2002-03-04 PL PL02363967A patent/PL363967A1/xx not_active Application Discontinuation
- 2002-03-04 EE EEP200300429A patent/EE200300429A/xx unknown
- 2002-03-04 CZ CZ20032266A patent/CZ20032266A3/cs unknown
- 2002-03-04 BR BR0207443-5A patent/BR0207443A/pt not_active IP Right Cessation
- 2002-03-04 YU YU69903A patent/YU69903A/sh unknown
- 2002-03-04 EP EP02713715A patent/EP1368034A1/en not_active Withdrawn
- 2002-03-04 JP JP2002574974A patent/JP2005506294A/ja active Pending
-
2003
- 2003-08-21 ZA ZA200306541A patent/ZA200306541B/xx unknown
- 2003-08-22 IS IS6925A patent/IS6925A/is unknown
- 2003-09-04 NO NO20033910A patent/NO20033910L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005506294A5 (cg-RX-API-DMAC7.html) | ||
| RU2003129527A (ru) | Способ и дозированная форма для опухолей путем введения тегафура, урацила, фолиновой кислоты, паклитаксела и карбоплатины | |
| ES2630002T5 (es) | Fármaco anticanceroso que contiene alfa,alfa,alfa-trifluorotimidina e inhibidor de timidina fosforilasa | |
| US9814724B2 (en) | Antitumor effect potentiator and antitumor agent | |
| JP2004534850A5 (cg-RX-API-DMAC7.html) | ||
| JP2019503365A5 (cg-RX-API-DMAC7.html) | ||
| RU2003114752A (ru) | Лечение желудочно-кишечных стромальных опухолей | |
| JP2006515883A5 (cg-RX-API-DMAC7.html) | ||
| JP2009514874A5 (cg-RX-API-DMAC7.html) | ||
| JP2002523502A5 (cg-RX-API-DMAC7.html) | ||
| JPH10279482A (ja) | ピリミジン誘導体の単独で又は他の治療方法と組み合わせた癌の予防のための使用 | |
| JP2007514754A5 (cg-RX-API-DMAC7.html) | ||
| JP2007501809A5 (cg-RX-API-DMAC7.html) | ||
| CN107296811A (zh) | 一种用于治疗胃癌的喹啉衍生物 | |
| JP2002525323A5 (cg-RX-API-DMAC7.html) | ||
| JP2006502132A5 (cg-RX-API-DMAC7.html) | ||
| AU2017215825B2 (en) | Method for treating cancer patients with severe renal impairment | |
| JP2004533434A5 (cg-RX-API-DMAC7.html) | ||
| CA2641713A1 (en) | Hydrate forms of amg706 | |
| NZ514014A (en) | Method of treating sleep apnoea | |
| JP2002536333A5 (cg-RX-API-DMAC7.html) | ||
| PT1634595E (pt) | Derivados de n-fenilbenzamida como fármacos para o tratamento doença pulmonar obstativa crónica (dpoc) | |
| US6620816B2 (en) | Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide | |
| RU97112236A (ru) | Способ лечения злокачественных опухолей кости и метастазов в кость остеолитического характера | |
| RU2007111754A (ru) | Применение мидостаурина для лечения желудочно-кишечных стромальных опухолей |